Clinical trial
Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With…
NCT00004127 · University of Chicago, Other · Completed
Key facts
| NCT number | NCT00004127 |
|---|---|
| Title | Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach |
| Official title | A Phase II Study of Oxaliplatin in Combination With Fluorouracil and Leucovorin in Carcinoma of the Esophagus and Gastric Cardia |
| Lead sponsor | University of Chicago, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer, Gastric Cancer |
| Intervention type | Drug |
| Interventions | FOLFOX regimen, fluorouracil, leucovorin calcium, oxaliplatin |
| Enrollment | 35 |
| Start date | Feb 1, 2000 |
| Primary completion | Oct 1, 2002 |
| Completion | Aug 1, 2003 |
| First posted | May 7, 2003 |
| Last update posted | Feb 11, 2013 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: